Pulmonary Sclerosing Hemangioma

This is a type of non-cancerous growth in the lungs. It's made up of cells that line the air sacs. It's called 'sclerosing' because it has areas that look like scar tissue.

Condition

What people with Pulmonary Sclerosing Hemangioma report

Every report comes from a Lived member, sent anonymously.

Have you had Video-Assisted Thoracic Surgery for Pulmonary Sclerosing Hemangioma?

NameHow it went

About Pulmonary Sclerosing Hemangioma

What It Is

Pulmonary sclerosing hemangioma is a rare lung tumor that is usually benign, meaning it does not behave like cancer. Today it is called sclerosing pneumocytoma. The old name came from a belief that it grew from blood vessels, because parts of it contain blood-filled spaces. Specialists now know it grows from the cells that line the lung's tiny air sacs, so it is not related to the hemangiomas that appear on the skin or in the liver. It usually shows up as a single round spot (a nodule) on a chest X-ray or CT (computed tomography) scan, most often in the lower part of a lung. Many people have no symptoms and learn about it only because a scan was done for another reason. When symptoms do occur, they tend to be mild and nonspecific, such as a cough, chest tightness or discomfort in the chest or back. Its main importance is that it can look very much like lung cancer until it is examined closely.

Causes & Risk Factors

The cause is not known. It is not linked to smoking, and nothing a person did is known to bring it on. It occurs much more often in women than in men, usually in middle age, though it has been found across a wide range of ages. Researchers have suggested that hormonal or genetic factors may play a role, but this has not been established. Most reported cases come from East Asia, and it is considered quite rare elsewhere. Whether that reflects a real difference in risk, or differences in screening and reporting, is not clear.

How It's Diagnosed

Because it appears as a lung nodule, the first question doctors try to answer is whether the spot could be lung cancer. A CT scan gives important clues: this tumor is usually smooth-edged, oval and well defined, may contain small calcium deposits, and tends to light up gradually after contrast dye is given. Blood tests for tumor markers are usually normal. A PET (positron emission tomography) scan, which shows how actively tissue uses sugar, is not always reassuring, because many of these tumors show some uptake and some show strong uptake, a pattern that can also be seen with cancer. Imaging can suggest the diagnosis but rarely settles it. A needle biopsy guided by CT can identify it, but the tumor contains a mix of cell types and patterns, so a small sample can be mistaken for lung adenocarcinoma (a common type of lung cancer) or another tumor. In one large hospital series, only about a third of cases were correctly identified before surgery. For many people, the diagnosis is confirmed only when the nodule is removed and a pathologist examines the whole tumor under the microscope, using special stains that distinguish it from cancer.

Treatment Options

Surgery to remove the nodule is the main treatment. It confirms the diagnosis, rules out cancer, and in most cases cures the condition. Many operations are now done by keyhole surgery through small incisions in the chest (thoracoscopic surgery). When the tumor is small, near the lung's surface and clearly identified, removing a small wedge or segment of lung is often enough, which preserves more lung tissue. A larger operation that removes a whole lobe of the lung (lobectomy) may be needed when the tumor sits in a difficult location or when lung cancer is found or suspected at the same time. During surgery, a quick microscope check of the tissue can help the surgeon decide how much to remove. For some small nodules that cause no symptoms and look typical on imaging, doctors may suggest watching the nodule with repeat CT scans instead of operating right away. This is a judgment call: some of these tumors barely change for years while others grow faster, and surgery is still recommended when cancer cannot be confidently ruled out.

What to Expect

The outlook is generally very good. Most people who have the nodule removed have no recurrence. In one hospital series, the average stay after surgery was about four days, and recovery afterward follows the usual course for the type of lung operation performed. The tumor is not always entirely harmless. A small number spread to nearby lymph nodes, and spread to bone, the liver or the lining of the lung has occasionally been reported, particularly in tumors with a lot of dense fibrous tissue. Even then, death from this tumor is extremely rare. Some people have more than one nodule, and this tumor sometimes occurs alongside a separate lung cancer or a neuroendocrine tumor, so each spot on the scan needs its own assessment. If the nodule is being watched rather than removed, expect repeat CT scans at intervals your doctor sets based on its size and how it has behaved. After surgery, any follow-up imaging depends on what the pathologist found. There is no single agreed follow-up schedule, because the tumor is rare and most information comes from individual hospitals.

When to Seek Help

If a scan has shown a lung nodule, make sure there is a clear plan for next steps, whether that is a biopsy, surgery or a date for a repeat scan, and keep the follow-up appointments. Contact your care team sooner if you develop new or worsening cough, chest discomfort or shortness of breath while a nodule is being watched, or if you have a new nodule after treatment. After surgery, follow your surgical team's instructions on which recovery problems to report.

Questions to Ask Your Doctor

  1. 1.How confident are you that this nodule is a sclerosing pneumocytoma rather than lung cancer, and what would make you more certain?
  2. 2.Would you recommend removing the nodule now or watching it with scans, and why?
  3. 3.If I have surgery, how much lung would need to be removed, and how would that affect my breathing and recovery?
  4. 4.Did the pathology report show anything unusual, such as spread to lymph nodes or another tumor, and what follow-up do I need?

Last reviewed • Oct 2026

Educational content, not medical advice.